UK Companies House feature
KD PHARMA UK LIMITED
Profile
- Company number
- 07614003
- Status
- Active
- Incorporation
- 2011-04-26
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 3 to the financial statements that describes the events and conditions that indicate that a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern.”
Significant events
- “Subsequent to the year end, as part of a wider O3 Group restructuring of operations, the company ceased production of Omega-3 products and changed its principal activity to the contract manufacture of small molecules.”
- “At the beginning of April 2025, as part of a wider restructuring of the O3 Group's global operations following the acquisition in 2024 of the Marine Lipids business from DSM-Firmenich AG, the company communicated to its employees a plan to cease the Omega 3 by the end of July 2025.”
- “On 6 January 2025, a fixed and floating charge was registered against the assets of the company as part of a wider O3 Group arrangement.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CARTWRIGHT, Ashley | Director | 2024-09-05 | Nov 1990 | British |
| ISMAIL, Adam Hameed | Director | 2026-05-05 | Jun 1977 | American |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MCELLONE, Michael | Secretary | 2017-08-01 | 2019-05-28 |
| AASAND, Anders | Director | 2011-04-26 | 2011-07-01 |
| ALTERMATT, Markus Karl | Director | 2019-05-28 | 2023-11-03 |
| ANDERSEN, Rolf | Director | 2017-08-01 | 2019-05-28 |
| BODD, Egil | Director | 2011-04-26 | 2011-07-01 |
| DAVIS, Andrew Thomas | Director | 2011-07-01 | 2013-07-24 |
| DECLEENE, James | Director | 2014-12-29 | 2017-08-01 |
| DINGSOR, Liv | Director | 2011-04-26 | 2011-07-01 |
| HAUGSTAD, Egil Magne | Director | 2017-08-01 | 2019-05-28 |
| MCELLONE, Michael | Director | 2017-08-01 | 2019-05-28 |
| MCRONALD, Stuart | Director | 2016-02-29 | 2017-08-01 |
| NORRIS, Eric Walton | Director | 2014-12-29 | 2017-08-01 |
| OLSEN, Sanne Marie Lokke | Director | 2023-04-01 | 2024-09-05 |
| PATTISON, Joseph Eliot | Director | 2013-07-24 | 2017-08-01 |
| SMITH, Michael Patrick | Director | 2013-07-24 | 2014-12-01 |
| SNOVE, Ola | Director | 2011-04-26 | 2013-07-24 |
| TRICKETT, Peter Stephen | Director | 2019-05-28 | 2023-04-01 |
| TRICKETT, Peter Stephen | Director | 2011-09-08 | 2016-02-29 |
| WIJEYERATNE, Gerard Ralph | Director | 2013-07-24 | 2014-12-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Epax Pharma Uk Holdings Unlimited | Corporate entity | Shares 75–100% | 2016-04-26 | Ceased 2019-05-28 |
Filing timeline
Last 20 of 141 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-05-06 | AP01 | officers | appoint person director company with name date |
| 2026-02-23 | MR05 | mortgage | mortgage charge whole release with charge number |
| 2025-07-14 | AA | accounts | accounts with accounts type full |
| 2025-07-14 | AA | accounts | accounts with accounts type full |
| 2025-06-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-01-07 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-12-09 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-09-17 | AP01 | officers | appoint person director company with name date |
| 2024-09-17 | TM01 | officers | termination director company with name termination date |
| 2024-05-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-11-30 | TM01 | officers | termination director company with name termination date |
| 2023-11-03 | AA | accounts | accounts with accounts type full |
| 2023-05-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-10 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
| 2023-04-11 | AP01 | officers | appoint person director company with name date |
| 2023-04-03 | TM01 | officers | termination director company with name termination date |
| 2022-09-07 | AA | accounts | accounts with accounts type full |
| 2022-05-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-24 | AA | accounts | accounts with accounts type full |
| 2021-05-11 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.